“Effect of Ranibizumab on High-Speed Indocyanine Green Angiography and Minimum Intensity Projection Optical Coherence Tomography Findings in Neovascular Age-Related Macular Degeneration”, Retina, vol. 35, pp. 58-68, 2015.
, “A Randomized 36-Week Crossover Trial Comparing Ranibizumab and Bevacizumab for Diabetic Macular Edema”, in 2015 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO), Denver, CO, 2015.
, “Circularity Index as a Risk Factor for Progression of Geographic Atrophy”, Ophthalmology, vol. 120, pp. 2666-2671, 2013.
, “Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical Trial”, Invest Ophthlmol Vis Sci, vol. 51, pp. 613-619, 2010.
, “Effects of Multivitamin/Mineral Supplementation on Plasma Levels of Nutrients. Report No. 4 of the Italian-American Clinical Trial of Nutritional Supplements and Age-Related Cataract”, Ann Ist Super Sanita, vol. 45, pp. 119-127, 2009.
, ,
“Intravitreal Anti-Vascular Endothelial Growth Factor Therapy with Pegaptanib for Advanced Von Hippel-Lindau Disease of the Retina”, Retina, vol. 27, pp. 150-158, 2007.
, “Visual Acuity as an Outcome Measure in Clinical Trials of Retinal Diseases”, Ophthalmology, vol. 114, pp. 1804-1809, 2007.
, “Dose Ranging Study of Lutein Supplementation in Persons Aged 60 Years or Older”, Invest Ophthalmol Vis Sci, vol. 47, pp. 5227-5233, 2006.
, “The Effect of Lutein and Zeaxanthin Supplementation on Metabolites of These Carotenoids in the Serum of Persons Aged 60 or Older”, Invest Ophthalmol Vis Sci, vol. 47, pp. 5234-5242, 2006.
, “A Simplified Severity Scale for Age-Related Macular Degeneration. AREDS Report No. 18”, Arch Ophthalmol, vol. 123, pp. 1570-1574, 2005.
, “The Long-Term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy: The Early Treatment Diabetic Retinopathy Follow-up Study”, Ophthalmology, vol. 110, pp. 1683-89, 2003.
,